Search Results - "Raihane Ben Lakhal"

Primary adrenal lymphoma by Kacem, Karima, Zriba, Sami, Lakhal, Raihane Ben, Bouteraa, Walid, Aissaoui, Lamia, Amor, Ramzi Ben, Abdennebi, Yosr Ben, Ali, Zaher Belhadj, Abid, Hela Ben, Meddeb, Balkis

“…Primary non-Hodgkin's lymphoma of the adrenal gland is rare. We report the case of a 56-year-old patient suffering from B symptoms. The CT scan showed a…”
Get full text

PB2368: THE PRE‐EMPTIVE STRATEGY OF HEPATITIS B VIRAL REACTIVATION IN PATIENTS WITH MALIGNANT HEMOPATHIES RECEIVING IMMUNSUPPRESSIVE THERAPY IN TUNISIA by Wafa, Miled, Jabeur, Dorra, Mansouri, Raoudha, Sayedi, Malek, Kacem, Karima, Lakhal, Raihane Ben

Get full text

PB2312: REACTIVATION OF HEPATITIS B VIRUS FOLLOWING RITUXIMAB IN B LYMPHOID HEMOPATHIES by Wafa, Miled, Jabeur, Dorra, Mansouri, Raoudha, Sayedi, Malek, Kacem, Karima, Lakhal, Raihane Ben

Get full text

PB1878: MYELOID SARCOMA IN CHILDREN: ABOUT 9 CASES by Yahia, Ameni, Bahri, Marwa, Rihab, Nefzi, Dhib, Asma, Lakhal, Raihane Ben, Abdennabi, Yosr Ben, Aissaoui, Lamia

Get full text

PB2365: CHILDHOOD BURKITT LYMPHOMA: ABOUT 31 CASES (EXPERIENCE OF THE PEDIATRIC CLINICAL HEMATOLOGY DEPARTMENT OF AZIZA OTHMANA’S HOSPITAL) by Rihab, Nefzi, Bahri, Marwa, Guerbouj, Hamida Khémiri, Yahia, Ameni, Lakhal, Raihane Ben, Abdennabi, Yosr Ben, Aissaoui, Lamia

Get full text

PB2286: EVALUATION OF THE THERAPEUTIC RESULTS OF LYMPHOBLASTIC LYMPHOMA TREATED ACCORDING TO THE EORTC 58951 PROTOCOL IN CHILDREN ADOLESCENTS AND YOUNG ADULTS by Hammamia, Hana Ben, Azza, Emna, Sahbani, Hela, Abdennabi, Yosr Ben, Daoud, Zied, Lakhal, Raihane Ben, Aissaoui, Lamia

Get full text

PB1746: EVOLUTION OF SARS‐COV‐2 INFECTION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA by Guerbouj, Hamida Khémiri, Bahri, Marwa, Moussa, Amine Ben, Inaam, Bizid, Zahmoul, Manel Hamdoun, Rejeb, Hela Hannechi, Bahri, Olfa, Lakhal, Raihane Ben, Abdennabi, Yosr Ben, Aissaoui, Lamia

Get full text

PB2320: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE by Zahra, Kmira, Belaid, Imtinène, Kacem, Karima, Elloumi, Moez, Mezlini, Amel, Msaddek, Fehmi, Tarek, Ben Othman, Nabil, Toumi, Lakhal, Raihane Ben, Khelif, Abderrahim, Slim, Ben Ahmed, Afef, Khanfir, Laatiri, Adnene

Get full text

PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE by Zahra, Kmira, Belaid, Imtinène, Kacem, Karima, Elloumi, Moez, Mezlini, Amel, Msaddek, Fehmi, Tarek, Ben Othman, Nabil, Toumi, Lakhal, Raihane Ben, Khelif, Abderrahim, Slim, Ben Ahmed, Afef, Khanfir, Laatiri, Adnene

Get full text

Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience) by Ben Lakhal, Raihane, Ghedira, Hela, Bellaaj, Hatem, Ben Youssef, Yosra, Menif, Samia, Manai, Zeineb, Bedoui, Manel, Lakhal, Amel, M’Sadek, Fehmi, Elloumi, Moez, Khélif, Abderrahmane, Ben Romdhane, Neila, Laatiri, Mohamed Adnène, Ben Othmen, Tarek, Meddeb, Balkis

“…Data are limited in developing countries regarding the clinicopathologic features and response to therapy of chronic myeloid leukemia (CML) in the era of…”
Get full text

Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes by Jeddi, Ramzi, Achour, Mériem, Amor, Ramzi Ben, Aissaoui, Lamia, Bouterâa, Walid, Kacem, Karima, Lakhal, Raihane Ben, Abid, Héla Ben, BelHadjAli, Zaher, Turki, Amel, Meddeb, Balkis

“…Severe sepsis defined as infection-induced organ dysfunction or hypoperfusion abnormalities predispose to septic shock and increased mortality in neutropenic…”
Get more information

Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections by Jeddi, Ramzi, Ghédira, Héla, Ben Amor, Ramzi, Turki, Amel, Kacem, Karima, Ben Abdennebi, Yosr, Ben Lakhal, Raihane, Aissaoui, Lamia, Ben Abid, Héla, Bel Hadjali, Zaher, Meddeb, Balkis

“…Pseudomonas is a clinically significant and opportunist pathogen, usually associated in causing high mortality nosocomial infections. The aim of this study was…”
Get more information

Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia by Jeddi, Ramzi, Kacem, Karima, Ben Neji, Hend, Mnif, Samia, Gouider, Emna, Aissaoui, Lamia, Ben Amor, Ramzi, Ben Lakhal, Raihane, Ben Abid, Hela, Belhadjali, Zaher, Meddeb, Balkis

“…The combination of all-trans-retinoic acid (ATRA) and chemotherapy has made acute promyelocytic leukemia (APL) a highly curable leukemia. However, several…”
Get full text

Treatment of Acute Promyelocytic Leukemia with AIDA Based Regimen. Update of a Tunisian Single Center Study by Jeddi, Ramzi, Ghédira, Hèla, Ben Amor, Ramzi, Ben Abdennebi, Yosr, Karima, Kacem, Mohamed, Zarrouk, Ben Neji, Hend, Aissaoui, Lamia, Ben Lakhal, Raihane, Ben Salah, Naouel, Menif, Samia, Belhadjali, Zaher, Ben Abid, Hela, Gouider, Emna, Hafsia, Raouf, Saad, Ali, Fenaux, Pierre, Meddeb, Balkis

“…In Tunisia, the ATRA era began in 1998 with the use, consecutively, of two regimens combining ATRA and an anthracycline with cytarabine (APL93), and without…”
Get full text

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN by Jeddi, Ramzi, Ghédira, Hèla, Ben Amor, Ramzi, Ben Abdennebi, Yosr, Karima, Kacem, Mohamed, Zarrouk, Ben Neji, Hend, Aissaoui, Lamia, Ben Lakhal, Raihane, Ben Salah, Naouel, Menif, Samia, Belhadjali, Zaher, Ben Abid, Hela, Gouider, Emna, Hafsia, Raouf, Saad, Ali, Fenaux, Pierre, Meddeb, Balkis

“…In Tunisia, the ATRA era began in 1998 with the use, consecutively, of two regimens combining ATRA and an anthracycline with cytarabine (APL93), and without…”
Get full text

Echanges plasmatiques au cours des purpuras thrombotiques thrombocytopéniques by Jabr, Dorra, Hsasna, Roua, Kéfi, Salma, Kharrat, Rachid, Ben Néji, Hend, Ben Lakhal, Raihane

“…Introduction : Le purpura thrombotique thrombocytopénique (PTT) est une pathologie hématologique rare mais potentiellement fatale en l’absence d’une prise en…”
Get full text

Chronic Myeloid Leukemia Patients In Tunisia: Epidemiology and Outcome In The Imatinib Era (A Multicentric Experience) by Ben Lakhal, Raihane, Ghedira, Hela, Bellaaj, Hatem, Ben Youssef, Yosra, Menif, Samia, Manai, Zeineb, Bedoui, Manel, Lakhal, Amel, Meddeb, Balkis

“…The introduction of the first targeted tyrosine kinase inhibitor (TKI), imatinib mesylate (IM) revolutionized the therapeutic paradigm and dramatically…”
Get full text

Molecular monitoring of Tunisian patients with chronic myeloid leukemia by Menif, Samia, Ben Youssef, Yosra, Bellaaj, Hatem, Ben Lakhal, Raihane, Laatiri, Adnen

“…bcr-abl fusion gene is the hallmark of chronic myeloid leukemia (CML). RQ-PCR provides an accurate measure of the total leukemia cell mass and the degree to…”
Get more information

Echanges plasmatiques au cours des purpuras thrombotiques thrombocytopéniques by Jabr, Dorra, Hsasna, Roua, Kefi, Salma, Kharrat, Rachid, Ben Neji, Hend, Ben Lakhal, Raihane

“…Introduction: Le purpura thrombotique thrombocytopénique (PTT) est une pathologie hématologique rare mais potentiellement fatale en l’absence d’une prise en…”
Get full text

Adult ALL Patients Treated with Pediatric Inspired Trials Have Inacceptable Early Death but Better Relapse Free Survival Compared to Adult Trials: A Tunisian Single Center Experience by Neji, Hend Ben, Abdennebi, Yosr Ben, Aissaoui, Lamia, Jeddi, Ramzi, Zarrouk, Mohamed, amor, Ramzi Ben, Kacem, Karima, Lakhal, Raihane Ben, Ali, Zaher Belhadj, Abid, Hela Ben, Meddeb, Balkis

“…Abstract 4297 In Tunisia children with acute lymphoblastic leukemia (ALL) are treated according to the EORTC 58951 protocol with complete remission rate (CR)…”
Get full text